
The IB-Stim device uses electrical pulses to stimulate cranial nerves and reduce pain associated with irritable bowel syndrome.

The IB-Stim device uses electrical pulses to stimulate cranial nerves and reduce pain associated with irritable bowel syndrome.

Despite less than 2% of patients receiving surgery, they accounted for more than 25% of total expenditures within 1 year of diagnosis.

A short account of patients I’ve known and not loved over the years.

Investigators found that the prevalence of asthma in patients with opioid dependence was more than double the national prevalence.

An investigational non-opioid pain medication, tanezumab demonstrated statistically significant pain reduction at 16 weeks compared to placebo.

Reformulation of OxyContin to prevent it being dissolved and injected prompted switching to heroin and a surge in hepatitis C infections.

The Second Chance app from University of Washington investigators is seeking FDA consideration in the near future.

New research finds patients face a higher risk of pneumonia if they are taking opioids. The danger is even more pronounced for patients living with HIV.

For patients with chronic liver disease, opioid prescriptions are common, and high-risk prescriptions are associated with hepatic decompensation, especially ascites.

The SynchroMed II myPTM Personal Therapy Manager allows patients with chronic pain to manage unpredictable pain by delivering on-demand doses within limits set by their provider.

High Impact Chronic Pain encompasses individuals with chronic pain who also have a disability. Data collected in this study will help improve care for patients with HICP and guide future research.

A small study found that ketamine decreased symptoms of depression—investigators studied its effects in combination with the opioid-blocker naltrexone compared to a placebo.

The director of Pain Management and Palliative Care at the Englewood Hospital & Medical Center in Englewood, NJ, explains how analgesics may come to the forefront of pain management care.

New research finds that the prevalence of opioid use remained high during the study period from 2007 to 2016.

A CDC analysis found that overall drug overdose death rates increased by 21.5%, but those involving synthetic opioids more than doubled.

Researchers in Pennsylvania want to bolster the scientific case for the use of medical marijuana as an alternative to opioids.

Although LY2828360 failed as a therapeutic option for osteopathic pain in phase 2, it may be granted new life as a neuropathic pain treatment.

These findings could be the first step in the design of therapies that are better able to target specific receptors to exert therapeutic effects.

Lead researcher Ben Seymour, PhD, noted that this brings medicine a step closer to harnessing the brain's natural pain relief system in a more specific way.

A new study finds clinical and economic advantages to the use of a multi-pronged pain management approach after surgery.

From July 2016 through September 2017, opioid overdoses have increased 35% in the CDC’s Enhanced State Opioid Overdose Surveillance's 16 participating states.

Remoxy ER is a thick, sticky, high-viscosity capsule formulation designed to deter abuse via injection, snorting and smoking.

Interventions are lacking for MSDs, which can result in lost time at work and early retirement.

Many people don't see low back pain as life-threatening, but it is.

Ketamine is not a new tool in the arsenal of pain medication but doctors are finding new ways to use it in order to provide relief for patients. As an infusion ketamine is being used to treat chronic pain syndromes.